Felipe Duran, the Chief Financial Officer of $IBIO ($IBIO), bought 9,191 shares of the company on 01-10-2025. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings by approximately 471.8%. Following this trade, they now own 11,139 shares of $IBIO stock.
$IBIO Insider Trading Activity
$IBIO insiders have traded $IBIO stock on the open market 7 times in the past 6 months. Of those trades, 7 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $IBIO stock by insiders over the last 6 months:
- FELIPE DURAN (Chief Financial Officer) purchased 9,191 shares.
- MARTIN BRENNER (See Remarks) purchased 9,191 shares.
- MARC BANJAK (Chief Legal Officer) purchased 9,191 shares.
- DAVID ARKOWITZ purchased 18,382 shares.
- WILLIAM D CLARK purchased 1,838 shares.
- ANTONIO BERNARDINO GUIMARAES PARADA purchased 183,823 shares.
- GARY SENDER purchased 9,191 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$IBIO Hedge Fund Activity
We have seen 6 institutional investors add shares of $IBIO stock to their portfolio, and 6 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- LYNX1 CAPITAL MANAGEMENT LP added 621,516 shares (+258.1%) to their portfolio in Q3 2024
- ADAR1 CAPITAL MANAGEMENT, LLC removed 93,788 shares (-16.5%) from their portfolio in Q3 2024
- UBS GROUP AG removed 40,668 shares (-100.0%) from their portfolio in Q3 2024
- DIMENSIONAL FUND ADVISORS LP added 24,071 shares (+inf%) to their portfolio in Q3 2024
- GEODE CAPITAL MANAGEMENT, LLC added 5,825 shares (+11.8%) to their portfolio in Q3 2024
- TOWER RESEARCH CAPITAL LLC (TRC) removed 1,157 shares (-34.4%) from their portfolio in Q3 2024
- CITIGROUP INC removed 173 shares (-80.5%) from their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
